Gabriel Alejandro Garibaldi

Mr. Gabriel Alejandro Garibaldi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in Biomicrofluidics
Verified
Journal Article
Closed access
PDF file
GRGuillermo Ramirez-Alvarado
Guillermo Ramirez-Alvarado
GGGabriel Alejandro Garibaldi
Gabriel Alejandro Garibaldi
CTChiraz Toujani
Chiraz Toujani
GSGongchen Sun
Gongchen Sun
Rapid prototyping and fabrication of microstructure have been revolutionized by 3D printing, especially stereolithography (SLA) based techniques due to the superior spatial resolution they offer. However, SLA-type 3D printing faces intrinsic challenges in multi-material integration and adaptive Z-layer slicing due to the use of a vat and a mechanically controlled Z-layer generation. In this paper, we present the conceptualization of a novel paradigm which uses dynamic and multi-phase laminar flow in a microfluidic channel to achieve fabrication of 3D objects. Our strategy, termed “in situ 3D polymerization,” combines in situ polymerization and co-flow aqueous two-phase systems and achieves slicing, polymerization, and layer-by-layer printing of 3D structures in a microchannel. The printing layer could be predicted and controlled solely by programming the fluid input. Our strategy provides generalizability to fit with different light sources, pattern generators, and photopolymers. The integration of the microfluidic channel could enable high-degree multi-material integration without complicated modification of the 3D printer.

15 July 2024 in MRS Communications
Verified
Journal Article
Closed access
PDF file
GGGabriel Alejandro Garibaldi
Gabriel Alejandro Garibaldi
GRGuillermo Ramirez-Alvarado
Guillermo Ramirez-Alvarado
MGMiguel Garibaldi
Miguel Garibaldi
GSGongchen Sun
Gongchen Sun

12 August 2025 in Micromachines
Verified
Journal Article
Open access
PDF file
GGGabriel Alejandro Garibaldi
Gabriel Alejandro Garibaldi
JAJimena Berenice Alegria
Jimena Berenice Alegria
ASAnita Shayan
Anita Shayan
RSRobert Stannert
Robert Stannert
Nehal Abu-LailNehal Abu-Lail
Nehal Abu-Lail
GSGongchen Sun
Gongchen Sun
Sorting and isolating specific cells from heterogeneous populations are crucial for many biomedical applications, including drug discovery and medical diagnostics. Conventional methods such as Fluorescent Activated Cell Sorting (FACS) and Magnetic Activated Cell Sorting (MACS) face limitations in throughput, cost, and the ability to separate subtly different cells. Cell partitioning in Aqueous Two-Phase Systems (ATPSs) offers a biocompatible and cost-effective alternative, particularly when combined with continuous-flow microfluidics. However, it remains challenging to rationally design microfluidic ATPS devices and operation to separate cells with similar origin but different phenotypes. In this paper, using a model ATPS, polyethylene glycol (PEG)—Dextran (Dex) system, and model cells, human chondrocytes (hChs), and carboxylated polystyrene (PS) microparticles, we systematically characterized the material properties affecting cell partitioning in ATPSs, such as surface energies of the solutions and cells and solution viscosities. We developed an energy balance approach between interfacial energy and viscous dissipation to estimate the interface translocation dynamic of cells partitioning into the preferred phase. Combining the experimental measurement and the energy balance model, our calculation reveals that the time required for complete cell partitioning at the ATPS interface can be exploited in microfluidic ATPS devices to separate hChs with different phenotypes (healthy and diseased). We expect our dynamic energy approach to provide a basis and a design strategy for optimizing microfluidic ATPS devices to achieve the efficient separation of phenotypically similar cell populations and further expand the potential of microfluidic cell separation.

31 October 2026 in Micromachines
Verified
Journal Article
Open access
PDF file
ACAlexia Cash
Alexia Cash
HFHunter Fitzpatrick
Hunter Fitzpatrick
GGGabriel Alejandro Garibaldi
Gabriel Alejandro Garibaldi
AFAnjelyka Fasci
Anjelyka Fasci
MLMaria J. Londono
Maria J. Londono
GSGongchen Sun
Gongchen Sun
Electroporation, a biophysical method that transiently permeabilizes cell membranes via externally applied electric pulses, has evolved from bulk, low-resolution approaches to highly controlled micro- and nano-electroporation (MEP/NEP) platforms. By inducing a transmembrane potential exceeding a critical threshold (≈0.5–1.5 V), nanoscale pores form, enabling delivery of nucleic acids, proteins, drugs, and probes without viral vectors or chemical carriers. Early work demonstrated efficient plasmid uptake in mouse lyoma cells using high-intensity, short-duration pulses, establishing the foundation for modern gene transfer applications. Contemporary MEP devices improve spatial and temporal field control, reducing voltage requirements and cellular damage, while NEP systems focus the electric field onto subcellular regions, magnifying the electrophoretic component of transport, which contributes to a lesser, cargo- and parameter-dependent degree in bulk and micro-electroporation as well, to achieve rapid, high-efficiency cargo delivery. Advances in device architecture, including microchannels, high aspect ratio nanostructures, nanochannel arrays, and nanofountain probes, have expanded capabilities across gene delivery, tissue engineering, drug screening, cell lysis, and cell fusion. Beyond cargo transport, the applied field is increasingly used as a biological stimulus, modulating extracellular vesicle secretion and cargo content for cell engineering and biomanufacturing. Nevertheless, challenges persist: achieving uniform pore geometry, preserving viability, scaling throughput, and translating in vitro designs to in vivo contexts. Ongoing innovations in electrode materials, fabrication techniques, and integrated microfluidic systems promise to overcome these barriers, positioning MEP/NEP as a versatile platform for accelerating biomedical research and therapeutic development.